FitzGerald also challenged Pfizer's contention that no science shows increased risk from Celebrex.
And a congressman requested the U.S. Food and Drug Adminstration answer questions about the medications used to treat arthritis, diagnosed in more than 49 million people.
Heavily advertised as an arthritis drug, Vioxx was pulled from the market last week after its maker said a study showed it doubled the risk of heart attack and stroke.
He did so voluntarily."
